A detailed history of Wms Partners, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Wms Partners, LLC holds 7,358 shares of ABBV stock, worth $1.25 Million. This represents 0.1% of its overall portfolio holdings.

Number of Shares
7,358
Previous 7,748 5.03%
Holding current value
$1.25 Million
Previous $1.2 Million 11.58%
% of portfolio
0.1%
Previous 0.09%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

SELL
$159.82 - $182.1 $62,329 - $71,019
-390 Reduced 5.03%
7,358 $1.34 Million
Q4 2023

Feb 12, 2024

SELL
$137.6 - $154.97 $446,924 - $503,342
-3,248 Reduced 29.54%
7,748 $1.2 Million
Q3 2023

Nov 09, 2023

SELL
$133.59 - $154.65 $138,666 - $160,526
-1,038 Reduced 8.63%
10,996 $1.64 Million
Q2 2023

Aug 14, 2023

SELL
$132.51 - $164.9 $16,961 - $21,107
-128 Reduced 1.05%
12,034 $1.62 Million
Q1 2023

May 12, 2023

SELL
$144.61 - $166.54 $63,773 - $73,444
-441 Reduced 3.5%
12,162 $1.94 Million
Q4 2022

Feb 07, 2023

SELL
$138.31 - $165.87 $28,768 - $34,500
-208 Reduced 1.62%
12,603 $2.04 Million
Q3 2022

Nov 08, 2022

SELL
$134.21 - $153.93 $3,221 - $3,694
-24 Reduced 0.19%
12,811 $1.72 Million
Q2 2022

Aug 05, 2022

BUY
$137.62 - $174.96 $23,395 - $29,743
170 Added 1.34%
12,835 $1.97 Million
Q1 2022

May 10, 2022

SELL
$131.98 - $163.75 $43,553 - $54,037
-330 Reduced 2.54%
12,665 $2.05 Million
Q4 2021

Feb 14, 2022

SELL
$107.43 - $135.93 $13,858 - $17,534
-129 Reduced 0.98%
12,995 $1.76 Million
Q3 2021

Nov 12, 2021

SELL
$106.4 - $120.78 $26,706 - $30,315
-251 Reduced 1.88%
13,124 $1.42 Million
Q2 2021

Aug 13, 2021

SELL
$105.21 - $117.21 $17,990 - $20,042
-171 Reduced 1.26%
13,375 $1.51 Million
Q1 2021

May 14, 2021

BUY
$102.3 - $112.62 $3,273 - $3,603
32 Added 0.24%
13,546 $1.47 Million
Q4 2020

Feb 17, 2021

SELL
$80.49 - $108.67 $804 - $1,086
-10 Reduced 0.07%
13,514 $1.45 Million
Q3 2020

Nov 12, 2020

SELL
$85.91 - $100.83 $51,116 - $59,993
-595 Reduced 4.21%
13,524 $1.19 Million
Q2 2020

Aug 12, 2020

BUY
$73.37 - $98.18 $189,441 - $253,500
2,582 Added 22.38%
14,119 $1.39 Million
Q1 2020

May 13, 2020

SELL
$64.5 - $97.79 $54,825 - $83,121
-850 Reduced 6.86%
11,537 $879,000
Q4 2019

Feb 13, 2020

SELL
$72.13 - $90.25 $29,573 - $37,002
-410 Reduced 3.2%
12,387 $1.1 Million
Q3 2019

Nov 07, 2019

SELL
$62.98 - $75.72 $102,972 - $123,802
-1,635 Reduced 11.33%
12,797 $969,000
Q2 2019

Aug 13, 2019

BUY
$65.7 - $83.98 $110,376 - $141,086
1,680 Added 13.17%
14,432 $1.05 Million
Q1 2019

May 13, 2019

BUY
$77.14 - $90.79 $77,911 - $91,697
1,010 Added 8.6%
12,752 $1.03 Million
Q4 2018

Feb 14, 2019

SELL
$77.85 - $96.01 $22,031 - $27,170
-283 Reduced 2.35%
11,742 $1.08 Million
Q3 2018

Nov 08, 2018

SELL
$88.91 - $98.84 $12,002 - $13,343
-135 Reduced 1.11%
12,025 $1.14 Million
Q2 2018

Aug 09, 2018

BUY
$89.78 - $106.23 $231,363 - $273,754
2,577 Added 26.89%
12,160 $1.13 Million
Q1 2018

May 14, 2018

SELL
$92.01 - $123.21 $11,409 - $15,278
-124 Reduced 1.28%
9,583 $907,000
Q4 2017

Feb 09, 2018

BUY
$89.56 - $98.21 $21,315 - $23,373
238 Added 2.51%
9,707 $939,000
Q3 2017

Oct 27, 2017

SELL
$69.85 - $89.22 $13,969 - $17,844
-200 Reduced 2.07%
9,469 $841,000
Q2 2017

Aug 09, 2017

BUY
N/A
9,669
9,669 $701,000

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $301B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Wms Partners, LLC Portfolio

Follow Wms Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wms Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wms Partners, LLC with notifications on news.